Do specific gene changes affect how much imatinib stays in my blood?

Yes, specific gene changes can affect how much imatinib stays in your blood. Imatinib is a tyrosine kinase inhibitor used to treat chronic myeloid leukemia (CML). Your body uses proteins called transporters to move drugs like imatinib in and out of cells. Variations in the genes that code for these transporters can change how much imatinib remains in your bloodstream. A meta-analysis found that certain genetic variants in the ABCB1 and ABCG2 genes are linked to higher imatinib levels in the blood ².

What the research says

A meta-analysis of nine studies including over 2,500 CML patients looked at how genetic variations in ABCB1 and ABCG2 affect imatinib trough levels (the lowest concentration of drug in your blood before your next dose) ². Patients with the ABCB1 c.3435C>T TT genotype had significantly higher imatinib levels compared to those with the CC genotype (mean difference 299.84 ng/mL) ². Similarly, the ABCB1 c.2677G>T GT and TT genotypes were associated with higher levels than the GG genotype ². For ABCG2, the c.412C>A CA variant also led to increased imatinib levels compared to CC ². These findings suggest that genetic testing could help doctors personalize imatinib dosing to improve effectiveness and reduce side effects ². Other sources discuss imatinib's effects on fertility ¹ and resistance mechanisms like the T315I mutation ³⁵, but they do not directly address how gene changes affect imatinib blood levels.

What to ask your doctor

• Should I have genetic testing for ABCB1 or ABCG2 variants before starting imatinib?
• Could my imatinib dose be adjusted based on my genetic profile?
• How will my imatinib blood levels be monitored during treatment?
• What are the signs that my imatinib level might be too high or too low?
• Are there other factors, like other medications or diet, that could affect my imatinib levels?